Journal of Inflammation Research

The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation

The Journal of Inflammation Research, together with Guest Advisors Dr. Reynold Panettieri and Dr. Cynthia Koziol-White, is pleased to invite you to submit your research to the upcoming Article Collection “The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation”.

All currently-approved pharmaceuticals have had the same humble beginnings – a hypothesis and experiment in a laboratory. Translational research is a crucial component in drug discovery, though results obtained using in vivo animal models such as mice do not always translate well from bench to bedside. Moreover, technological advancements have made it possible to study aspects of inflammatory processes we never thought possible.

The field of translational immunology allows researchers to learn more about inflammatory processes contributing to airway disorders such as asthma and allergy. These inflammatory airway disorders are found in over 25 million individuals worldwide, and severe inflammatory responses can lead to hospitalization and even death. Preclinical and clinical research have led to the identification and production of drugs with new therapeutic targets, such as interleukin-4, interleukin-1, interleukin-33 and thymic stromal lymphopoietin.

The Guest Advisors welcome relevant clinical Original Research, Reviews, Reports, Hypothesis Formation, Commentaries, and Expert Opinions up until the 31st March 2026. These articles may pertain broadly to translational immunology of asthma and allergy, though special attention will be given to the following subareas:

1. Novel in vitro, in vivo, and ex vivo models to study airway inflammation such as organoids
2. New therapeutic targets
3. Genome-wide CRISPR screening for drug discovery
4. Translational information derived from Single-cell RNA seq
5. Whole tissue dynamics using spatial transcriptomics
6. Exome sequencing
7. Immunological synapses between immune cells and structural/mesenchymal cells

Upon submission, please use the promo code 79538 for 10% off the advertised article processing charge and indicate that your manuscript will be considered for the “The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation” Collection. Please contact the Commissioning Editor, Ashley Ambros, with any questions concerning this Collection.

Keywords: Asthma; Allergy; Drug Discovery; Translational Immunology

Reynold A. Panettieri Jr., MD is Professor of Medicine, Vice Chancellor for Translational Medicine and Science at Rutgers University, and the Director of the Institute for Translational Medicine and Science.  He is the recipient of numerous honors and awards, including the Robert E. Cooke Memorial Lectureship at the American Academy of Allergy, Asthma and Immunology Annual Meeting; the Joseph R. Rodarte Award for Scientific Distinction; and the Recognition Award for Scientific Accomplishments from the American Thoracic Society (ATS). Dr. Panettieri was principal investigator on several NIH-sponsored grants and industry-sponsored clinical studies. He is the Director of a program project grant examining novel approaches in modulating G protein-coupled receptor function, and is the Principal Investigator of New Jersey’s only CTSA Hub entitled ‘New Jersey Alliance for Clinical and Translational Science’.  He is the author of over 525 peer-reviewed publications. Dr. Panettieri manages the comprehensive clinical care of patients with asthma and is engaged in clinical investigations focused on the management of asthma and COPD.

Cynthia J. Koziol-White, PhD obtained a PhD in Molecular and Cellular Pharmacology from University of Wisconsin-Madison.  She completed two postdoctoral fellowships at University of Pennsylvania, one in mucosal immunology and the other in respiratory pharmacology. In 2016 she was appointed to an Instructor position at Rutgers University and promoted to Assistant Professor in the Department of Pharmacology in the Robert Wood Johnson School of Medicine in 2019. Cynthia’s research interests include respiratory pharmacology, with specific emphasis on understanding how GPCR signalling in airway smooth is altered in the inflammatory milieu in asthma and virus-induced exacerbations of asthma. She is interested in how structural cells of the airways modulate the function of one another, and how this translates to alterations in responsiveness to respiratory therapeutics in the context of disease. Dr. Koziol-White has received both training grant awards and travel awards through various societies and the NIH. Cynthia has served as the Co-Editor-in-Chief of Current Research in Pharmacology and Drug Discovery since 2020, and is a member of editorial boards for Respiratory Research, Pulmonary Pharmacology and Therapeutics, and British Journal of Pharmacology.  She is an active member of the American Thoracic Society Respiratory Structure Function assembly, serving on the Programming Committee.